Statements (59)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Horizon_Therapeutics
|
| gptkbp:founded |
2000
|
| gptkbp:founder |
Dr. John A. McGowan
|
| gptkbp:headquarters |
gptkb:Lake_Forest,_Illinois
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ovation Pharmaceuticals
|
| gptkbp:products |
gptkb:Cystagon
gptkb:Elaprase gptkb:Lurbinectedin gptkb:Yescarta gptkb:Zeposia gptkb:Actimmune gptkb:Xyrem gptkb:Abecma gptkb:Brineura gptkb:Simponi gptkb:Tysabri gptkb:Cerdelga gptkb:Nucala gptkb:Ocrevus gptkb:Buphenyl gptkb:Vimizim Nexavar Rituxan Xolair Dupixent DaxibotulinumtoxinA Aubagio Kalydeco Breyanzi Stelara Vaxneuvance Zynteglo Gazyva Skyrizi Rinvoq Cimzia Ravicti Carvykti Cerezyme Breztri Xeljanz Tazverik Kymriah Entyvio Kineret Takhzyro Vyndaqel Cinqair Fasenra Lumizyme OnabotulinumtoxinA Orfadin Tezspire Vpriv Zavesca Zepzelca Rylaze |
| gptkbp:specializesIn |
rare diseases
|